The invention relates to nutritional compositions comprising lactose.calcium salt co-crystals and to the use of these co-crystals for preparing nutritional compositions, as carrier, filler or stabilizer, for accelerating lactose dissolution as well as for efficient calcium fortification of compositions. Furthermore, the present invention is directed to a process for preparing such lactose.calciumsalt co-crystals and nutritional compositions comprising such.

The invention relates to nutritional compositions comprising lactose.calcium salt co-crystals and to the use of these co-crystals for preparing nutritional compositions, as carrier, filler or stabilizer, for accelerating lactose dissolution as well as for efficient calcium fortification of compositions. Furthermore, the present invention is directed to a process for preparing such lactose.calciumsalt co-crystals and nutritional compositions comprising such.

A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.

A nutritional composition is used to reconstitute an optimal healthy microbiota ecosystem in humans or animals. In particular, an ingestible carrier contains specific amino acids designed to favor the growth of bacteria favorable to individuals health or for reducing the risk of developing deleterious events. In another aspect, specific amino acids are used to reconstitute an optimal healthy microbiota ecosystem in humans or animals, in particular in infants, critically ill patients, in the case of chronic diseases or any stresses impacting the gut and in elderly people.

The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.

The invention relates to a nutritional composition comprising (a) at least 18 en % of proteinaceous matter, said proteinaceous matter comprising whey; (b) at least 12 wt % of leucine, based on total proteinaceous matter; and (c) a lipid fraction comprising at least a ?-3 polyunsaturated fatty acid selected from the group of eicosapentaenoic acid, docosahexaenoic acid, eicosatetraenoic acid and docosapentaenoic acid for improving the muscle function in a mammal, for improving daily activity, for improving physical performance, for providing a better prognosis in terms of extended life-expectancy, for improving compliance to an anti-cancer therapy or for improving a quality of life.

A nutritional composition for infants at risk of developing obesity later in life comprises a protein source, a lipid source and a carbohydrate source and has a protein content of less than 1.8 g/100 kcal and an energy density of less than 650 kcal/liter.

A nutritional composition for infants at risk of developing obesity later in life comprises a protein source, a lipid source and a carbohydrate source and has a protein content of less than 1.8 g/100 kcal and an energy density of less than 650 kcal/liter.

The present disclosure provides nutritional compositions comprising a synergistic effective amount of a NAD pre-cursor in a combination with an ATP booster. The disclosure provides methods and formulations to enhance natural energy. The disclosure also provides methods and formulations treat mitochondrial energy disorders or diseases.

The present disclosure provides nutritional compositions comprising a synergistic effective amount of a NAD pre-cursor in a combination with an ATP booster. The disclosure provides methods and formulations to enhance natural energy. The disclosure also provides methods and formulations treat mitochondrial energy disorders or diseases.